RE: https://newsie.social/@STAT/116369440554418902

"A decade ago, these drugs tore apart the FDA. Today, they might be some patients’ best hope

Once-divisive ‘exon-skipping’ treatments for Duchenne muscular dystrophy are showing startling promise"

By Jason Mast
April 8, 2026

LinkedIn past tracker wall:

https://archive.ph/V9f6f

#Netherlands #Dutch #medicalResearch #medicine